| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |